HUP0204116A3 - Methods of treating short stature disorders related to the short stature homeobox-containing (shox) gene - Google Patents

Methods of treating short stature disorders related to the short stature homeobox-containing (shox) gene

Info

Publication number
HUP0204116A3
HUP0204116A3 HU0204116A HUP0204116A HUP0204116A3 HU P0204116 A3 HUP0204116 A3 HU P0204116A3 HU 0204116 A HU0204116 A HU 0204116A HU P0204116 A HUP0204116 A HU P0204116A HU P0204116 A3 HUP0204116 A3 HU P0204116A3
Authority
HU
Hungary
Prior art keywords
short stature
shox
gene
methods
disorders related
Prior art date
Application number
HU0204116A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Rappold Hoerbrand Gudrun
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22594056&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0204116(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rappold Hoerbrand Gudrun filed Critical Rappold Hoerbrand Gudrun
Publication of HUP0204116A2 publication Critical patent/HUP0204116A2/hu
Publication of HUP0204116A3 publication Critical patent/HUP0204116A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU0204116A 1999-11-09 2000-11-08 Methods of treating short stature disorders related to the short stature homeobox-containing (shox) gene HUP0204116A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16434199P 1999-11-09 1999-11-09
PCT/IB2000/001612 WO2001034181A2 (en) 1999-11-09 2000-11-08 Methods of treating short stature disorders related to the short stature homeobox-containing (shox) gene

Publications (2)

Publication Number Publication Date
HUP0204116A2 HUP0204116A2 (hu) 2003-03-28
HUP0204116A3 true HUP0204116A3 (en) 2005-07-28

Family

ID=22594056

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0204116A HUP0204116A3 (en) 1999-11-09 2000-11-08 Methods of treating short stature disorders related to the short stature homeobox-containing (shox) gene

Country Status (8)

Country Link
EP (1) EP1227832A2 (cs)
JP (1) JP2003513934A (cs)
AU (1) AU1292201A (cs)
CA (1) CA2390632A1 (cs)
CZ (1) CZ20021718A3 (cs)
HU (1) HUP0204116A3 (cs)
PL (1) PL357471A1 (cs)
WO (1) WO2001034181A2 (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060172929A1 (en) * 2003-01-13 2006-08-03 Gudrun Rappold-Hoerbrand Use of natriuretic peptides for the treatment of stature disorders related to the shox gene

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824642A (en) * 1994-04-07 1998-10-20 Genentech, Inc. Treatment of partial growth hormone insensitivity syndrome
US5631225A (en) * 1994-10-13 1997-05-20 Novo Nordisk A/S Pharmaceutical formulation

Also Published As

Publication number Publication date
EP1227832A2 (en) 2002-08-07
CA2390632A1 (en) 2001-05-17
WO2001034181A3 (en) 2001-12-06
HUP0204116A2 (hu) 2003-03-28
CZ20021718A3 (cs) 2002-11-13
AU1292201A (en) 2001-06-06
PL357471A1 (en) 2004-07-26
WO2001034181A2 (en) 2001-05-17
JP2003513934A (ja) 2003-04-15

Similar Documents

Publication Publication Date Title
AU7722600A (en) Compositions and methods for the diagnosis and treatment of immune disorders
AU2001271973A1 (en) Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
HUP0103856A3 (en) Pharmaceutical composition for the treatment of acute disorders
AU6910600A (en) Methods for the treatment of mental disorders
AU3086900A (en) Device for the complex treatment of disorders of the prostate
AU4078997A (en) Cholinesterase inhibitors for treatment of parkinson's disease
IL155589A0 (en) Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
IL153425A0 (en) Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders
ZA200107689B (en) 1-Arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of CNS disorders.
IL141263A0 (en) Methods for treatment of neurological disorders
AU5309600A (en) Compositions and methods for the treatment and diagnosis of immune disorders
AU2001271887A1 (en) Methods for diagnosis and treatment of psychiatric disorders
ZA973622B (en) Use of forms of hyaluronic acid (HA) for the treatment of cancer.
AU3760400A (en) Methods and reagents for the diagnosis and treatment of multiple sclerosis
AU6425800A (en) Agents for the diagnosis, prognosis and treatment of malignant diseases
ZA985818B (en) Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders.
IL139023A0 (en) Process for the preparation of 2,3,5-trimethyl-p- benzoquinone
AU3757300A (en) Method of treating anxiety disorders
IL133760A0 (en) Composition for the treatment of dandruff
CZ20011872A3 (cs) Isonipekotamidy pro léčbu onemocnění zprostředkovaných integriny
ZA200110539B (en) Oxazinocarbazoles for the treatment of CNS diseases.
PL357471A1 (en) Methods of treating short stature disorders related to the short stature homeobox-containing (shox) gene
AU3899100A (en) Treatment of hyperactivity disorders
WO2001011039A3 (de) Sequenzvarianten des menschlichen 1-adrenozeptorgens und ihre verwendung
AU4838301A (en) Treatment of disorders relating to the serotonergic system

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished